MDRC logo
Explore
REGULATORY INTELLIGENCE

Medical device software compliance in the EU and US

Medical software is not regulated only by its code. Its regulatory status depends on intended purpose, clinical role, risks, evidence and the way the software is developed and maintained. MDRC helps companies define the regulatory pathway and build the documentation and processes required for market access.

Is your software a medical device?

Not every healthcare software product is regulated as a medical device. The regulatory status depends on the intended purpose, functions performed, clinical role and the impact of software outputs on healthcare decisions.

Medical device software

Software may be regulated as a medical device when it performs a medical purpose or provides information used for diagnosis, prevention, monitoring, prediction or treatment decisions.

  • Clinical decision support systems
  • Diagnostic algorithms
  • AI-based image or signal analysis
  • Patient monitoring software
  • Software influencing clinical decisions

Software outside MDR and IVDR

Not all healthcare-related software is a medical device. Applications without a medical intended purpose may fall outside MDR or IVDR requirements.

  • Administrative healthcare systems
  • Electronic documentation tools
  • Scheduling and workflow software
  • General wellness applications
  • Communication and data management tools

The intended purpose, not the technology itself, determines the regulatory status.

?

Key regulatory questions

Before selecting a regulatory pathway, companies should define:

  • What is the intended purpose?
  • Who is the intended user?
  • Does the software influence clinical decisions?
  • What risks can result from incorrect outputs?
  • What evidence is required?
  • Which regulatory pathway applies?

Classification determines the regulatory pathway

Medical software classification is one of the first regulatory decisions a company must make. It determines the level of regulatory control, evidence requirements, documentation scope and the pathway to market access.

For software, classification depends not only on the technology itself, but on the intended purpose, clinical role and impact of the software outputs.

Medical software

Intended purpose and clinical function

What is the intended purpose?

What healthcare function does the software perform? Who uses it and how are outputs applied?

No medical purpose

Software may fall outside medical device regulation, depending on its function and claims.

Medical purpose

Further assessment of clinical role, risks and regulatory requirements is required.

MDR / IVDR classification

Regulatory pathway, evidence requirements and conformity assessment route

01

Intended purpose

The intended purpose defines whether software is considered a medical device and establishes the foundation for classification.

  • Healthcare task performed
  • Intended users
  • Clinical context
  • Software claims
02

Clinical impact and risk

Classification depends on how software outputs influence healthcare decisions and the potential consequences of incorrect results.

  • Diagnosis support
  • Treatment recommendations
  • Patient monitoring
  • Risk of harm
03

Regulatory consequence

The classification determines the documentation, evidence and quality requirements needed for market access.

  • Technical documentation
  • Risk management
  • Clinical evidence
  • Notified Body involvement
MDRC helps companies classify software products correctly before major development and documentation decisions are made. Early classification reduces regulatory uncertainty and prevents costly rework.

Regulatory framework for medical software

Medical software compliance is not defined by a single standard. Successful market access requires alignment between regulatory requirements, software development processes, risk controls, clinical evidence and quality management.

MDRC helps companies connect these elements into one coherent regulatory strategy from early development decisions through technical documentation and regulatory assessment.

EU MDR / IVDR
Classification, General Safety and Performance Requirements, technical documentation and conformity assessment.
FDA / SaMD
Software functions, regulatory pathway, documentation expectations and US market access.
Medical software
Intended purpose, clinical role, product claims and market pathway.
01

Software development and control

The development process must be structured, traceable and controlled throughout the software lifecycle.

  • IEC 62304
  • Software planning
  • Requirements and architecture
  • Verification and validation
  • Change management and maintenance
02

Safety and performance

Compliance depends on how risks are identified, controlled and linked to safe and effective use of the software.

  • ISO 14971
  • Cybersecurity considerations
  • Usability engineering
  • IEC 62366-1
  • Benefit-risk logic
03

Evidence and quality

The software must be supported by evidence, documented appropriately and maintained within an effective quality system.

  • Clinical evaluation
  • Technical documentation
  • ISO 13485
  • Post-market surveillance
  • Assessment readiness

IEC 62304 and the software lifecycle

Medical device software is assessed not only by its final functionality. Regulators and Notified Bodies need evidence that software was developed, verified, maintained and changed through a controlled lifecycle process.

IEC 62304 provides the framework for managing software development activities and ensuring that processes are planned, documented and traceable.

Software lifecycle IEC 62304 Planning Development strategy Requirements Architecture and traceability Implementation Development activities Verification and validation Evidence of compliance Release Deployment and monitoring Maintenance Updates and changes

Planning and requirements

Software development begins with controlled definition of the product, its intended purpose, safety classification, requirements and verification approach.

Development and verification

IEC 62304 requires structured software engineering processes including architecture, implementation, testing, verification and traceability.

Maintenance and changes

Software updates, cybersecurity changes and defect corrections must be controlled, assessed and documented to maintain compliance after release.

IEC 62304 compliance is not achieved by creating documents after development is complete. It requires regulatory thinking to be integrated into the software development process from the beginning.

Clinical evidence and performance evaluation

Medical software compliance requires more than demonstrating that the software functions correctly. Manufacturers must provide evidence that the software performs its intended purpose and that its outputs are clinically meaningful, reliable and safe for the intended users.

The type and depth of evidence depend on the intended purpose, risk class, clinical role and claims made by the manufacturer.

Higher regulatory impact Higher evidence expectations

Clinical claims

Demonstrated clinical value and intended benefits

Clinical evaluation and validation

Clinical relevance, benefit-risk assessment and justification of claims

Performance evaluation

Performance metrics, validation datasets and reliability assessment

Technical verification

Software testing, algorithm verification and data quality assessment

Software development and risk controls

Requirements, lifecycle processes, cybersecurity and risk management

Technical performance

Demonstrates that the software functions as designed.

  • Algorithm performance
  • Accuracy and reliability
  • Verification and validation
  • Data quality assessment
  • Cybersecurity controls

Performance validation

Demonstrates that software outputs are consistent and reliable.

  • Sensitivity and specificity
  • Performance metrics
  • Reference comparison
  • Independent validation datasets
  • AI model evaluation

Clinical evaluation

Demonstrates that the software provides meaningful clinical value.

  • Clinical claims
  • Clinical benefit
  • Benefit-risk assessment
  • Literature evidence
  • Clinical investigation data when required
Clinical evidence is not added at the end of software development. It should influence product decisions, intended purpose, claims and validation strategy from the beginning.

Cybersecurity, AI and evolving software risks

Connected medical software and AI-enabled technologies introduce new types of risks that must be managed throughout the product lifecycle.

Regulatory compliance requires control of data, algorithms, updates and system behaviour, not only protection against software defects.

Medical software AI • data • connectivity Cybersecurity Protection throughout lifecycle Data integrity Data quality and reliability AI reliability Model performance and monitoring Lifecycle changes Updates and continuous control

Cybersecurity throughout the lifecycle

Medical software must remain secure not only at release, but throughout operation and maintenance.

  • Cybersecurity risk assessment
  • Secure software architecture
  • Access control and authentication
  • Vulnerability management
  • Security updates

AI-specific considerations

AI-enabled software introduces additional questions related to data, model behaviour and ongoing performance.

  • Training and validation data quality
  • Bias and representativeness
  • Algorithm performance monitoring
  • Transparency and explainability
  • Human oversight

Post-market control

Software does not remain unchanged after release. Changes must be assessed and controlled.

  • Real-world performance monitoring
  • Change impact assessment
  • Risk updates
  • Documentation maintenance
  • Continuous compliance
AI can accelerate software development and documentation. It cannot replace cybersecurity assessment, risk management or regulatory responsibility.

Why software projects fail regulatory assessment

Medical software projects often fail not because the technology is insufficient, but because regulatory considerations are addressed too late or treated as documentation tasks rather than as part of product development.

Regulatory assessment evaluates the connection between intended purpose, software functionality, risks, evidence and development processes.

01

Regulatory strategy starts too late

Common problem

Regulatory decisions are made after software development is already advanced.

Consequence

Wrong classification, additional evidence requirements or costly redesign.

MDRC approach

Define the regulatory pathway before critical product decisions are made.

02

Documentation is not the regulatory argument

Common problem

Technical documentation is treated as a collection of separate documents.

Consequence

Missing connection between intended purpose, risks, evidence and requirements.

MDRC approach

Build a structured compliance argument supported by appropriate evidence.

03

Software lifecycle gaps

Common problem

Software development processes lack sufficient traceability and control.

Consequence

Assessment findings related to requirements, verification, validation or changes.

MDRC approach

Align software lifecycle activities with IEC 62304 expectations.

04

AI requires regulatory judgment

Common problem

AI-generated documentation is used without sufficient regulatory interpretation.

Consequence

Incorrect assumptions about classification, evidence or risk controls.

MDRC approach

Use AI as a productivity tool while maintaining expert regulatory responsibility.

AI can accelerate regulatory work. It cannot take responsibility for regulatory decisions. MDRC combines software development understanding with medical device regulatory expertise to help companies make informed decisions before problems appear during assessment.

Is your medical software ready for regulatory assessment?

We help companies define the pathway, identify evidence requirements and prepare documentation for Notified Body and FDA review.

Discuss your project

Discuss your regulatory pathway

Whether you are developing medical software, an AI-enabled healthcare solution, a digital health platform or a software-driven medical device, we can help define the regulatory strategy, evidence requirements and next steps.

Where companies need support

Regulatory strategy
Technical documentation
Clinical and performance evidence
Software lifecycle and cybersecurity
Notified Body readiness

Start a discussion

 

Regulatory support for software medical devices, AI health technologies and digital healthcare solutions.


©2026 MDRC - Medical Devices Regulatory Compliance

Useful information

CE-Certificate vs. EC-Certificate

Basic UDI-DI (bUDI)

EUDAMED registration - a brief guide

Authorised Representative Mandate

GSPR – General Safety and Performance Requirements

How to obtain CE marking for medical software under the EU MDR or IVDR?

Technical documentation for Medical Device Software in the EU

Read more >>


Cookie Policy

We only use essential cookies that enable core functionality and proper operation of the website. These cookies do not store any personally identifiable data. By continuing to use this website, you consent to the use of the essential cookies. You may disable these cookies by changing your browser settings, but this may affect how the website functions.
We do not use our own or third-party analytical, preferences, statistics, marketing, functional, advertisement, performance or any other non-essential cookies.

Send us an email:
info@mdrc-services.com

Or use the contact form below

 

Solutions

EU Authorised Representative (EC REP)

EU PRRC

Technical documentation

Risk management

Clinical evaluation

Notified Bodies

Quality management system

Post-market surveillance

Resources

Medical Device Regulation (MDR) - basics

CE-marking process for medical devices

CE-marking process for in vitro diagnostic medical devices

MDR technical documentation checklist

IVDR technical documentation checklist

Technical documentation checklist for medical device software (MDSW)

MDR-compliant quality system documentation checklist

MDR-compliant quality system documentation checklist for medical device software

Clinical Evaluation Plan checklist

Clinical Evaluation Report checklist

PRRC under MDR or IVDR

Articles

CE-Certificate vs. EC-Certificate

Basic UDI-DI (bUDI)

EUDAMED registration - a brief guide

Authorised Representative Mandate

GSPR – General Safety and Performance Requirements

More articles >>

Devices

General medical devices and equipment

In vitro diagnostics (IVD)

Medical software

Cookie Policy

We only use essential cookies that enable core functionality and proper operation of the website. These cookies do not store any personally identifiable data. By continuing to use this website, you consent to the use of the essential cookies. You may disable these cookies by changing your browser settings, but this may affect how the website functions.
We do not use our own or third-party analytical, preferences, statistics, marketing, functional, advertisement, performance or any other non-essential cookies.